Skip to main content
TipRanks
Go Ultimate75% OFF

C4 Therapeutics (CCCC) Drug Pipeline

699 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Dexamethasone, CemsidomideMultiple Myeloma, Relapsed/Refractory Multiple MyelomaPhase IIRecruitingA Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaDec 09, 2025―
Elranatamab, CemsidomideMultiple Myeloma (Mm)Phase INot Yet RecruitingA Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma SubjectsDec 01, 2025
Cetuximab, Trametinib, Cft1946Crc, Atc, Melanoma, Solid Tumors, NsclcPhase IActive Not RecruitingA Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid TumorsDec 06, 2022―
Cft8634Synovial Sarcoma, Soft Tissue SarcomaPhase ITerminatedA Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null TumorsApr 23, 2022―
Dexamethasone Oral, CemsidomideLymphoma, Non-Hodgkin's, Multiple MyelomaPhase IActive Not RecruitingStudy to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple MyelomaFeb 12, 2021―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does C4 Therapeutics, Inc. (CCCC) have in its pipeline
C4 Therapeutics CCCC is currently developing the following drugs: Dexamethasone, Cemsidomide, Elranatamab, Cemsidomide, Cetuximab, Trametinib, Cft1946, Cft8634, Dexamethasone Oral, Cemsidomide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.